Search
Now showing items 1-1 of 1
Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
(Elsevier, 2016)
Background
Schizophrenia is a costly illness to treat, especially during a time of escalating medicine inflation costs, putting a large economic strain on patients, their families and the community. Treatment, however, ...